no statement of use filed
on 15 Jan 2024
Last Applicant/ Owned by
6502 113th Avenue NE
Kirkland
WA
980337105
Serial Number
97081506 filed on 19th Oct 2021
Registration Number
N/A
Correspondent Address
MELISSA A. NOWAK, REG. NO. 68,088
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
custom design and engineering of antibody-derived antigen binding molecules and antibody-derived recombinant antigen binding molecules; Providing a bioinformatics platform as a service (PAAS) featuring computer software for developing antibody-derived antigen binding molecules and antibody-derived recombinant antigen binding molecules; Custom design and engineering of antibodies; Custom design andRead More
custom design and engineering of antibody-derived antigen binding molecules and antibody-derived recombinant antigen binding molecules; Providing a bioinformatics platform as a service (PAAS) featuring computer software for developing antibody-derived antigen binding molecules and antibody-derived recombinant antigen binding molecules; Custom design and engineering of antibodies; Custom design and engineering of antigens; Antibody engineering; Biochemical research and development; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Development and establishment of testing specifications and procedures in the field of biotechnology; Research and development in the pharmaceutical and biotechnology fields; Scientific research in the development of new cancer therapies; Scientific research in human and animal cell therapy; Platform as a service (PAAS) featuring computer software platforms for analysis of bioinformatic data
custom manufacture of therapeutic drugs, namely, custom manufacture of cell therapies and cancer therapies; Manufacture of pharmaceuticals, pharmaceutical ingredients, vaccines and antibodies for others
pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical products for the diagnosis, prevention and treatment of cancer; Antibodies being pharmaceutical preparations for the diagnosis, treatment and prevention of cancer, immune response disorders, genetic conditions, infectious diseases and vascular diseases; Vaccines; Pharmaceutical preparations for cell therapy; Preparations of blood extracted from humans or animals which have been adapted for medical or therapeutic purposes
biochemicals, namely, antibody-derived antigen binding molecules and antibody-derived recombinant antigen binding molecules for in vitro scientific or research use
No 97081506
No Service Mark
No 4768-T2US
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 16th Jan 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 15th Jan 2024 | ABANDONMENT - NO USE STATEMENT FILED |
| 13th Jun 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 18th Apr 2023 | PUBLISHED FOR OPPOSITION |
| 18th Apr 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 29th Mar 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 13th Mar 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 08th Mar 2023 | EXAMINERS AMENDMENT -WRITTEN |
| 08th Mar 2023 | EXAMINERS AMENDMENT E-MAILED |
| 08th Mar 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
